Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Genest

Showing results (501-510 of 521) with videos related to

Pageof 53
Sort By:
Regulatory Peptides. Supplement|January 1, 1985
Involvement of cytosolic free calcium in the action mechanism of atrial natriuretic factor (ANF)R Garay, P Hannaert, F Rodrigue, et al.
Biochemical and Biophysical Research Communications|August 15, 1985
Identification of a biologically active circulating form of rat atrial natriuretic factorG Thibault, C Lazure, E L Schiffrin, et al.
Transactions of the Association of American Physicians|January 1, 1985
On the circulating form of atrial natriuretic factorM Cantin, J Genest, G Thibault, et al.
Hypertension (Dallas, Tex. : 1979)|June 1, 1989
Atrial natriuretic factor in Purkinje fibers of rabbit heartM B Anand-Srivastava, G Thibault, C Sola, et al.
The American Journal of Cardiology|March 1, 1990
Effect of elective hospitalization on plasma lipoprotein cholesterol and apolipoproteins A-I, B and Lp(a)J J Genest, J R McNamara, J M Ordovas, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|June 1, 1986
Cyclic GMP as mediator and biological marker of atrial natriuretic factorP Hamet, J Tremblay, S C Pang, et al.
Regulatory Peptides. Supplement|January 1, 1985
Biochemical aspects of a new hormone: rat atrial natriuretic factor (rANF)G Thibault, R Garcia, J Gutkowska, et al.
The Canadian Journal of Cardiology|February 2, 2006
Rationale, design and baseline characteristics of a large, simple, randomized trial of combined folic acid and vitamins B6 and B12 in high-risk patients: the Heart Outcomes Prevention Evaluation (HOPE)-2 trialE Lonn, C Held, J M O Arnold, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1984
Amino acid sequence of homologous rat atrial peptides: natriuretic activity of native and synthetic formsN G Seidah, C Lazure, M Chrétien, et al.
Atherosclerosis|March 11, 1991
Restriction fragment length polymorphisms of the apolipoprotein A-I, C-III, A-IV gene locus. Relationships with lipids, apolipoproteins, and premature coronary artery diseaseJ M Ordovas, F Civeira, J Genest, et al.
Pageof 53

Showing results (501-510 of 521) with videos related to

Sort By:
Pageof 53
Regulatory Peptides. Supplement|January 1, 1985
Involvement of cytosolic free calcium in the action mechanism of atrial natriuretic factor (ANF)R Garay, P Hannaert, F Rodrigue, et al.
Biochemical and Biophysical Research Communications|August 15, 1985
Identification of a biologically active circulating form of rat atrial natriuretic factorG Thibault, C Lazure, E L Schiffrin, et al.
Transactions of the Association of American Physicians|January 1, 1985
On the circulating form of atrial natriuretic factorM Cantin, J Genest, G Thibault, et al.
Hypertension (Dallas, Tex. : 1979)|June 1, 1989
Atrial natriuretic factor in Purkinje fibers of rabbit heartM B Anand-Srivastava, G Thibault, C Sola, et al.
The American Journal of Cardiology|March 1, 1990
Effect of elective hospitalization on plasma lipoprotein cholesterol and apolipoproteins A-I, B and Lp(a)J J Genest, J R McNamara, J M Ordovas, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|June 1, 1986
Cyclic GMP as mediator and biological marker of atrial natriuretic factorP Hamet, J Tremblay, S C Pang, et al.
Regulatory Peptides. Supplement|January 1, 1985
Biochemical aspects of a new hormone: rat atrial natriuretic factor (rANF)G Thibault, R Garcia, J Gutkowska, et al.
The Canadian Journal of Cardiology|February 2, 2006
Rationale, design and baseline characteristics of a large, simple, randomized trial of combined folic acid and vitamins B6 and B12 in high-risk patients: the Heart Outcomes Prevention Evaluation (HOPE)-2 trialE Lonn, C Held, J M O Arnold, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1984
Amino acid sequence of homologous rat atrial peptides: natriuretic activity of native and synthetic formsN G Seidah, C Lazure, M Chrétien, et al.
Atherosclerosis|March 11, 1991
Restriction fragment length polymorphisms of the apolipoprotein A-I, C-III, A-IV gene locus. Relationships with lipids, apolipoproteins, and premature coronary artery diseaseJ M Ordovas, F Civeira, J Genest, et al.
Pageof 53